|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size 5/03/21 Morgan Stanley 10-Q 3/31/21 148:35M |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 3.69M
2: EX-3.1 Articles of Incorporation/Organization or Bylaws HTML 1.08M
3: EX-15 Letter re: Unaudited Interim Financial Info HTML 49K
4: EX-31.1 Certification -- §302 - SOA'02 HTML 45K
5: EX-31.2 Certification -- §302 - SOA'02 HTML 45K
6: EX-32.1 Certification -- §906 - SOA'02 HTML 42K
7: EX-32.2 Certification -- §906 - SOA'02 HTML 42K
14: R1 Cover Page HTML 118K
15: R2 Consolidated Income Statements (Unaudited) HTML 144K
16: R3 Consolidated Comprehensive Income Statements HTML 78K
(Unaudited)
17: R4 Consolidated Balance Sheets HTML 141K
18: R5 Consolidated Balance Sheets (Parenthetical) HTML 72K
19: R6 Consolidated Statements of Changes in Total Equity HTML 97K
(Unaudited)
20: R7 Consolidated Cash Flow Statements (Unaudited) HTML 135K
21: R8 Introduction and Basis of Presentation HTML 52K
22: R9 Significant Accounting Policies HTML 44K
23: R10 Acquisitions HTML 68K
24: R11 Cash and Cash Equivalents HTML 50K
25: R12 Fair Values HTML 654K
26: R13 Fair Value Option HTML 90K
27: R14 Derivative Instruments and Hedging Activities HTML 426K
28: R15 Investment Securities HTML 256K
29: R16 Collateralized Transactions HTML 151K
30: R17 Loans, Lending Commitments and Related Allowance HTML 363K
for Credit Losses
31: R18 Other Assets - Equity Method Investments HTML 53K
32: R19 Deposits HTML 57K
33: R20 Borrowings and Other Secured Financings HTML 60K
34: R21 Commitments, Guarantees and Contingencies HTML 127K
35: R22 Variable Interest Entities and Securitization HTML 251K
Activities
36: R23 Regulatory Requirements HTML 151K
37: R24 Total Equity HTML 216K
38: R25 Interest Income and Interest Expense HTML 67K
39: R26 Income Taxes HTML 46K
40: R27 Segment, Geographic and Revenue Information HTML 216K
41: R28 Significant Accounting Policies (Policies) HTML 50K
42: R29 Acquisitions (Tables) HTML 70K
43: R30 Cash and Cash Equivalents (Tables) HTML 48K
44: R31 Fair Values (Tables) HTML 846K
45: R32 Fair Value Option (Tables) HTML 84K
46: R33 Derivative Instruments and Hedging Activities HTML 438K
(Tables)
47: R34 Investment Securities (Tables) HTML 259K
48: R35 Collateralized Transactions (Tables) HTML 158K
49: R36 Loans, Lending Commitments and Related Allowance HTML 364K
for Credit Losses (Tables)
50: R37 Other Assets - Equity Method Investments (Tables) HTML 54K
51: R38 Deposits (Tables) HTML 58K
52: R39 Borrowings and Other Secured Financings (Tables) HTML 60K
53: R40 Commitments, Guarantees and Contingencies (Tables) HTML 106K
54: R41 Variable Interest Entities and Securitization HTML 257K
Activities (Tables)
55: R42 Regulatory Requirements (Tables) HTML 149K
56: R43 Total Equity (Tables) HTML 257K
57: R44 Interest Income and Interest Expense (Tables) HTML 67K
58: R45 Segment, Geographic and Revenue Information HTML 222K
(Tables)
59: R46 Acquisitions - Narrative (Details) HTML 60K
60: R47 Acquisitions - Purchase Price Allocation (Details) HTML 75K
61: R48 Acquisitions - Acquired Intangible Assets HTML 60K
(Details)
62: R49 Acquisitions - Proforma Combined Financial HTML 47K
Information (Details)
63: R50 Cash and Cash Equivalents - Summary (Details) HTML 52K
64: R51 Fair Values - Assets and Liabilities Measured at HTML 221K
Fair Value on a Recurring Basis (Details)
65: R52 Fair Values - Detail of Loans and Lending HTML 57K
Commitments at Fair Value (Details)
66: R53 Fair Values - Detail of Unsettled Fair Value of HTML 46K
Futures Contracts (Details)
67: R54 Fair Values - Activity of Level 3 Assets and HTML 172K
Liabilities Measured at Fair Value on a Recurring
Basis (Details)
68: R55 Fair Values - Valuation Techniques and Sensitivity HTML 351K
of Unobservable Inputs Used in Level 3 Fair Value
Measurements (Details)
69: R56 Fair Values - Fund Interests Measured Based on Net HTML 64K
Asset Value (Details)
70: R57 Fair Values - Assets and Liabilities Measured at HTML 88K
Fair Value on a Nonrecurring Basis (Details)
71: R58 Fair Values - Financial Instruments Not Measured HTML 112K
at Fair Value (Details)
72: R59 Fair Value Option - Borrowings Measured at Fair HTML 56K
Value on a Recurring Basis (Details)
73: R60 Fair Value Option - Net Revenues from Borrowings HTML 48K
under the Fair Value Option (Details)
74: R61 Fair Value Option - Gains (Losses) Due to Changes HTML 60K
in Instrument-Specific Credit Risk (Details)
75: R62 Fair Value Option - Difference Between Contractual HTML 47K
Principal and Fair Value (Details)
76: R63 Fair Value Option - Fair Value Loans on Nonaccrual HTML 45K
Status (Details)
77: R64 Derivative Instruments and Hedging Activities - HTML 189K
Fair Values of Derivative Contracts (Details)
78: R65 Derivative Instruments and Hedging Activities - HTML 119K
Notionals of Derivative Contracts (Details)
79: R66 Derivative Instruments and Hedging Activities - HTML 81K
Gains (Losses) on Accounting Hedges and Fair Value
Hedges (Details)
80: R67 Derivative Instruments and Hedging Activities - HTML 45K
Economic Loan Hedges (Details)
81: R68 Derivative Instruments and Hedging Activities - HTML 45K
Net Derivative Liabilities and Collateral Posted
(Details)
82: R69 Derivative Instruments and Hedging Activities - HTML 49K
Incremental Collateral and Termination Payments
upon Potential Future Ratings Downgrade (Details)
83: R70 Derivative Instruments and Hedging Activities - HTML 103K
Maximum Potential Payout/Notional of Credit
Protection Sold (Details)
84: R71 Derivative Instruments and Hedging Activities - HTML 59K
Fair Value Asset/(Liability) of Credit Protection
Sold (Details)
85: R72 Derivative Instruments and Hedging Activities - HTML 55K
Protection Purchased with CDS (Details)
86: R73 Investment Securities - AFS and HTM Securities HTML 107K
(Details)
87: R74 Investment Securities - Investment Securities in HTML 82K
an Unrealized Loss Position (Details)
88: R75 Investment Securities - Narrative (Details) HTML 45K
89: R76 Investment Securities - Investment Securities by HTML 192K
Contractual Maturity (Details)
90: R77 Investment Securities - Gross Realized Gains HTML 47K
(Losses) on Sales of AFS Securities (Details)
91: R78 Collateralized Transactions - Offsetting of HTML 110K
Certain Collateralized Transactions (Details)
92: R79 Collateralized Transactions - Gross Secured HTML 79K
Financing Balances (Details)
93: R80 Collateralized Transactions - Assets Loaned or HTML 43K
Pledged (Details)
94: R81 Collateralized Transactions - Collateral Received HTML 45K
(Details)
95: R82 Collateralized Transactions - Securities HTML 42K
Segregated for Regulatory Purposes (Details)
96: R83 Collateralized Transactions - Customer Margin HTML 42K
Lending (Details)
97: R84 Loans, Lending Commitments and Related Allowance HTML 92K
for Credit Losses - Loans by Type (Details)
98: R85 Loans, Lending Commitments and Related Allowance HTML 139K
for Credit Losses - Loans Held for Investment
before Allowance by Origination Year (Details)
99: R86 Loans, Lending Commitments and Related Allowance HTML 52K
for Credit Losses - Past Due Loans Held for
Investment before Allowance (Details)
100: R87 Loans, Lending Commitments and Related Allowance HTML 54K
for Credit Losses - Nonaccrual Loans Held for
Investment before Allowance (Details)
101: R88 Loans, Lending Commitments and Related Allowance HTML 46K
for Credit Losses - Troubled Debt Restructurings
(Details)
102: R89 Loans, Lending Commitments and Related Allowance HTML 94K
for Credit Losses - Allowance for Credit Losses
Rollforward - Loans and Lending Commitments
(Details)
103: R90 Loans, Lending Commitments and Related Allowance HTML 62K
for Credit Losses - Employee Loans (Details)
104: R91 Other Assets - Equity Method Investments - HTML 48K
Balances (Details)
105: R92 Other Assets - Equity Method Investments - Joint HTML 46K
Ventures (Details)
106: R93 Deposits - Summary (Details) HTML 50K
107: R94 Deposits - Time Deposit Maturities (Details) HTML 55K
108: R95 Borrowings and Other Secured Financings - HTML 56K
Borrowings (Details)
109: R96 Borrowings and Other Secured Financings - Other HTML 48K
Secured Financings (Details)
110: R97 Commitments, Guarantees and Contingencies - HTML 83K
Commitments (Details)
111: R98 Commitments, Guarantees and Contingencies - HTML 102K
Obligations under Guarantee Arrangements (Details)
112: R99 Commitments, Guarantees and Contingencies - HTML 61K
Narrative (Details)
113: R100 Variable Interest Entities and Securitization HTML 60K
Activities - Assets and Liabilities by Type of
Activity (Details)
114: R101 Variable Interest Entities and Securitization HTML 74K
Activities - Assets and Liabilities by Balance
Sheet Caption (Details)
115: R102 Variable Interest Entities and Securitization HTML 114K
Activities - Non-Consolidated VIEs (Details)
116: R103 Variable Interest Entities and Securitization HTML 65K
Activities - Mortgage and Asset Backed
Securitization Assets (Details)
117: R104 Variable Interest Entities and Securitization HTML 84K
Activities - Transferred Assets with Continuing
Involvement (Details)
118: R105 Variable Interest Entities and Securitization HTML 69K
Activities - Fair Value of Transfers of Assets
with Continuing Involvement (Details)
119: R106 Variable Interest Entities and Securitization HTML 51K
Activities - Proceeds from New Securitization
Transactions and Sales of Loans (Details)
120: R107 Variable Interest Entities and Securitization HTML 56K
Activities - Assets Sold with Retained Exposure
(Details)
121: R108 Regulatory Requirements - Risk-Based Regulatory HTML 88K
Capital Ratio Requirements (Details)
122: R109 Regulatory Requirements - The Firm's Regulatory HTML 77K
Capital and Capital Ratios (Details)
123: R110 Regulatory Requirements - U.S. Bank Subsidiaries' HTML 104K
Regulatory Capital and Capital Ratios (Details)
124: R111 Regulatory Requirements - U.S. Broker-Dealer HTML 46K
Regulatory Capital Requirements (Details)
125: R112 Total Equity - Preferred Stock Outstanding HTML 80K
(Details)
126: R113 Total Equity - Narrative (Details) HTML 46K
127: R114 Total Equity - Common Stock Repurchases (Details) HTML 43K
128: R115 Total Equity - Common Shares Outstanding for Basic HTML 50K
and Diluted EPS (Details)
129: R116 Total Equity - Dividends (Details) HTML 76K
130: R117 Total Equity - Accumulated Other Comprehensive HTML 69K
Income (Loss) (Details)
131: R118 Total Equity - Components of Period Changes in OCI HTML 119K
(Details)
132: R119 Interest Income and Interest Expense - Summary HTML 68K
(Details)
133: R120 Interest Income and Interest Expense - Accrued HTML 45K
Interest (Details)
134: R121 Segment, Geographic and Revenue Information - HTML 139K
Selected Financial Information by Business Segment
(Details)
135: R122 Segment, Geographic and Revenue Information - HTML 53K
Institutional Securities - Investment Banking
Revenues (Details)
136: R123 Segment, Geographic and Revenue Information - HTML 54K
Trading Revenues by Product Type (Details)
137: R124 Segment, Geographic and Revenue Information - HTML 42K
Investment Management Investments Revenues - Net
Unrealized Carried Interest (Details)
138: R125 Segment, Geographic and Revenue Information - HTML 42K
Investment Management Asset Management Revenues -
Reduction of Fees due to Fee Waivers (Details)
139: R126 Segment, Geographic and Revenue Information - HTML 42K
Other Expenses - Transaction Taxes (Details)
140: R127 Segment, Geographic and Revenue Information - Net HTML 51K
Revenues by Region (Details)
141: R128 Segment, Geographic and Revenue Information - HTML 42K
Revenue Recognized from Prior Services (Details)
142: R129 Segment, Geographic and Revenue Information - HTML 43K
Receivables from Contracts with Customers
(Details)
143: R130 Segment, Geographic and Revenue Information - HTML 52K
Assets by Business Segment (Details)
144: R9999 Uncategorized Items - ms-20210331.htm HTML 50K
146: XML IDEA XML File -- Filing Summary XML 289K
13: XML XBRL Instance -- ms-20210331_htm XML 12.32M
145: EXCEL IDEA Workbook of Financial Reports XLSX 231K
9: EX-101.CAL XBRL Calculations -- ms-20210331_cal XML 469K
10: EX-101.DEF XBRL Definitions -- ms-20210331_def XML 1.82M
11: EX-101.LAB XBRL Labels -- ms-20210331_lab XML 3.45M
12: EX-101.PRE XBRL Presentations -- ms-20210331_pre XML 2.35M
8: EX-101.SCH XBRL Schema -- ms-20210331 XSD 413K
147: JSON XBRL Instance as JSON Data -- MetaLinks 730± 1.17M
148: ZIP XBRL Zipped Folder -- 0000895421-21-000334-xbrl Zip 1.33M
| Document |
| Filed on Form S-3: | Filed on Form S-8: | |||||||
| Registration Statement No. 33-57202 | Registration Statement No. 33-63024 | |||||||
| Registration Statement No. 33-60734 | Registration Statement No. 33-63026 | |||||||
| Registration Statement No. 33-89748 | Registration Statement No. 33-78038 | |||||||
| Registration Statement No. 33-92172 | Registration Statement No. 33-79516 | |||||||
| Registration Statement No. 333-07947 | Registration Statement No. 33-82240 | |||||||
| Registration Statement No. 333-27881 | Registration Statement No. 33-82242 | |||||||
| Registration Statement No. 333-27893 | Registration Statement No. 33-82244 | |||||||
| Registration Statement No. 333-27919 | Registration Statement No. 333-04212 | |||||||
| Registration Statement No. 333-46403 | Registration Statement No. 333-28141 | |||||||
| Registration Statement No. 333-46935 | Registration Statement No. 333-28263 | |||||||
| Registration Statement No. 333-76111 | Registration Statement No. 333-62869 | |||||||
| Registration Statement No. 333-75289 | Registration Statement No. 333-78081 | |||||||
| Registration Statement No. 333-34392 | Registration Statement No. 333-95303 | |||||||
| Registration Statement No. 333-47576 | Registration Statement No. 333-55972 | |||||||
| Registration Statement No. 333-83616 | Registration Statement No. 333-85148 | |||||||
| Registration Statement No. 333-106789 | Registration Statement No. 333-85150 | |||||||
| Registration Statement No. 333-117752 | Registration Statement No. 333-108223 | |||||||
| Registration Statement No. 333-129243 | Registration Statement No. 333-142874 | |||||||
| Registration Statement No. 333-131266 | Registration Statement No. 333-146954 | |||||||
| Registration Statement No. 333-155622 | Registration Statement No. 333-159503 | |||||||
| Registration Statement No. 333-156423 | Registration Statement No. 333-159504 | |||||||
| Registration Statement No. 333-178081 | Registration Statement No. 333-159505 | |||||||
| Registration Statement No. 333-200365 | Registration Statement No. 333-168278 | |||||||
| Registration Statement No. 333-200365-12 | Registration Statement No. 333-172634 | |||||||
| Registration Statement No. 333-221595 | Registration Statement No. 333-177454 | |||||||
| Registration Statement No. 333-221595-01 | Registration Statement No. 333-183595 | |||||||
| Registration Statement No. 333-250103 | Registration Statement No. 333-188649 | |||||||
| Registration Statement No. 333-250103-01 | Registration Statement No. 333-192448 | |||||||
| Registration Statement No. 333-253728 | Registration Statement No. 333-204504 | |||||||
| Registration Statement No. 333-211723 | ||||||||
| Filed on Form S-4: | Registration Statement No. 333-218377 | |||||||
| Registration Statement No. 333-25003 | Registration Statement No. 333-231913 | |||||||
| Registration Statement No. 333-237743 | ||||||||
| Registration Statement No. 333-251157 | ||||||||
| /s/ Deloitte & Touche LLP | ||
| New York, New York | ||
| May 3, 2021 | ||
| This ‘10-Q’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 5/3/21 | 424B2, FWP | ||
| For Period end: | 3/31/21 | 13F-HR, 424B2, FWP | ||
| List all Filings | ||||